{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":5,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":5,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"9d1c7172ce5d","filters":{"venue":"FarFar - Pharmacy Repository"}},"results":[{"id":"W7132956291","doi":"","title":"Structural analysis of PEGylated nanoemulsions using EPR spectroscopy – the impact of an active compound incorporated in stabilizing layer","year":2023,"lang":"en","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Proteins in Food Systems","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Homogenizer; Bioavailability; Drug delivery; Polyvinyl alcohol; Phospholipid; Aqueous solution; Aqueous two-phase system; PEG ratio","authors":[{"name":"Jelena Đoković","is_ca":false},{"name":"Sotiria Demisli","is_ca":false},{"name":"Vassiliki Papadimitriou","is_ca":false},{"name":"Snežana Savić","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09693790705801955,"gpt":0.3679130291362785,"spread":0.2709751220782589,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003578207,0.0001794994,0.0004359694,0.0001246407,0.0002233598,0.00003559429,0.0004007585,0.00005968543,0.00006876173],"category_scores_gemma":[0.00002866597,0.00006718092,0.000249097,0.003057939,0.0001329496,0.0002280255,0.0001172582,0.0001947745,0.000001634496],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001603937,"about_ca_system_score_gemma":0.00004390041,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01310161,"about_ca_topic_score_gemma":0.0005027033,"domain_scores_codex":[0.9980494,0.0005110166,0.0005439474,0.0003075793,0.0003058461,0.0002822541],"domain_scores_gemma":[0.9989443,0.0001991539,0.0004704071,0.000162568,0.0001480539,0.00007551414],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001257554,0.00004993273,0.09709675,0.000005272022,0.0003363612,0.00001422765,0.0004599576,0.008676728,0.8928552,0.000002406737,0.000006930328,0.0003704738],"study_design_scores_gemma":[0.0001978458,0.0001358139,0.3945974,0.00001897112,0.0001283895,0.000009094967,0.0006324042,0.08353152,0.5205792,0.00003639075,0.000005723629,0.0001272303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990439,0.00007653475,6.239885e-7,0.000021726,0.0001499294,0.0003875397,0.0001206488,0.00005989992,0.0001392454],"genre_scores_gemma":[0.9997794,0.000004468569,0.00003112372,0.000004491244,0.00007169643,0.000008438579,0.0000852035,0.000002597921,0.00001259595],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.372276,"threshold_uncertainty_score":0.9934703,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7133016376","doi":"","title":"A proposal of innovative injectability assessment method for intravenous formulations - case study on PEGylated nanoemulsions","year":2022,"lang":"en","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Advanced Drug Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Homogenizer; Biocompatibility; Drug delivery; Compounding; Dosage form; Aqueous two-phase system; Critical quality attributes","authors":[{"name":"Jelena Đoković","is_ca":false},{"name":"Sanela Savić","is_ca":false},{"name":"Nebojša Cekić","is_ca":false},{"name":"Snežana Savić","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1308664773748046,"gpt":0.5091508657235977,"spread":0.3782843883487931,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.001965256,0.0003782894,0.0005902442,0.0003239886,0.001763643,0.00001719822,0.0003810827,0.0001010414,0.0002538934],"category_scores_gemma":[0.0001095738,0.0003857131,0.0001817644,0.0009504985,0.0001364323,0.000187857,0.0003129331,0.001329257,0.000005098053],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006829181,"about_ca_system_score_gemma":0.0006714932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004357075,"about_ca_topic_score_gemma":0.00001671237,"domain_scores_codex":[0.9942319,0.002924046,0.001170398,0.0007161296,0.0004511908,0.0005063406],"domain_scores_gemma":[0.9964679,0.001476645,0.000708505,0.0005055906,0.0006546372,0.0001867056],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005030526,0.02211027,0.06816737,0.0003496094,0.002848995,0.003779575,0.03555144,0.08622945,0.7362823,0.001863614,0.003226176,0.0345606],"study_design_scores_gemma":[0.04031315,0.01557042,0.009271308,0.000056155,0.002254025,0.01246865,0.06981549,0.2793104,0.4101146,0.0009542581,0.1569059,0.002965643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9808797,0.00009530415,0.007945312,0.0001605752,0.00261971,0.006022903,0.0006861377,0.0001900876,0.00140032],"genre_scores_gemma":[0.9918404,0.000001959452,0.004818221,0.0002740686,0.0001964166,0.002238983,0.00008747089,0.00006267417,0.00047987],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3261678,"threshold_uncertainty_score":0.9998595,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7132860175","doi":"","title":"Biocompatible nanoemulsions as a tool for preclinical testing of CW-02-79, a pyrazoloquinolinone modulator of sigma-2 receptors: preformulation and formulation studies","year":2023,"lang":"en","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biocompatible material; In vivo; Receptor; In vitro; Drug discovery; Preclinical testing","authors":[{"name":"Tanja Ilić","is_ca":false},{"name":"Tijana Stanković","is_ca":false},{"name":"Jelena Mitrović","is_ca":false},{"name":"Ivana Pantelić","is_ca":false},{"name":"James M. Cook","is_ca":false},{"name":"Snežana Savić","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08510945275508523,"gpt":0.3928485805724067,"spread":0.3077391278173214,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004424573,0.0001957369,0.0003476753,0.00009240147,0.0001606782,0.00001051259,0.0001289135,0.0001278705,0.000005796473],"category_scores_gemma":[0.0007179515,0.0001677353,0.0001387599,0.0002293718,0.00008721591,0.00002274124,0.0001836566,0.0000869436,0.000001978809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002377603,"about_ca_system_score_gemma":0.00007069662,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002209936,"about_ca_topic_score_gemma":8.622968e-7,"domain_scores_codex":[0.9984666,0.00008720823,0.0005964847,0.0003989069,0.0001862385,0.0002645761],"domain_scores_gemma":[0.9987493,0.0003035756,0.0003552301,0.000195531,0.0003072345,0.00008909989],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004394299,0.0001173518,0.00375644,0.0002860723,0.0001683719,9.951577e-7,0.0001337108,0.0008204975,0.9853849,0.0000590631,0.0004638798,0.008369241],"study_design_scores_gemma":[0.00159179,0.0009877534,0.002381145,0.0001007044,0.00009826649,0.000006515393,0.00005306883,0.01414802,0.9779691,0.0003343763,0.002136808,0.0001924468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971306,0.0008678369,0.0003581856,0.00003400802,0.0005104953,0.0009482506,0.00002684894,0.00005374458,0.00007000183],"genre_scores_gemma":[0.9966053,0.0003222421,0.002250445,0.00004620713,0.0002597939,0.000169704,0.00007967651,0.00002671896,0.0002399347],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01332752,"threshold_uncertainty_score":0.6840045,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7132617467","doi":"","title":"Komparativna analiza promene sistema za refundaciju lekova i politike cena lekova u zemljama EU","year":2006,"lang":"","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Regional Development and Management Studies","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"European union; European commission; Mercantilism; Quarter (Canadian coin)","authors":[{"name":"A. Božović-Marković","is_ca":false},{"name":"Guenka Petrova","is_ca":false},{"name":"Ljiljana Tasić","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04510589546980879,"gpt":0.2550810434584335,"spread":0.2099751479886247,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00091479,0.001280515,0.001918985,0.001070617,0.001650727,0.0007591192,0.001102395,0.0002525524,0.0007679514],"category_scores_gemma":[0.00003946109,0.001536205,0.0008268015,0.001219805,0.0005250899,0.001251918,0.0007352001,0.0006350823,0.001535237],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009967599,"about_ca_system_score_gemma":0.0002189674,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002020037,"about_ca_topic_score_gemma":0.00004815882,"domain_scores_codex":[0.991873,0.0001882973,0.003426511,0.002208374,0.0004672658,0.00183655],"domain_scores_gemma":[0.9960007,0.000132566,0.002062633,0.001118987,0.000286668,0.000398444],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007077194,0.002801264,0.2184573,0.00248436,0.004637813,0.001185028,0.001650973,0.0005323749,0.001967044,0.2453283,0.518307,0.001940837],"study_design_scores_gemma":[0.003205365,0.0001424594,0.06342401,0.0002064402,0.0002306488,0.00009524102,0.0002526633,0.001777496,0.00192372,0.003050264,0.9238408,0.001850907],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.1669996,0.05438351,0.0009145595,0.006911627,0.009977194,0.002678476,0.0002864802,0.0004203922,0.7574281],"genre_scores_gemma":[0.7968739,0.00394953,0.0005077799,0.0009433473,0.002137175,0.0002198308,0.00018403,0.0001543036,0.1950301],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6298743,"threshold_uncertainty_score":0.9999947,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7132978064","doi":"","title":"Meta-analysis of the data on differences in the exposure to psychiatric drugs between poor and normal cYP2C19/CYP2D6 metabolizers","year":2022,"lang":"sr","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"CYP2C19; Pharmacogenetics; Psychosis; Significant difference","authors":[{"name":"F. Milosavljević","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2470309766629272,"gpt":0.42380895361854,"spread":0.1767779769556129,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005148015,0.0009114844,0.002361594,0.001049632,0.001816763,0.0001300361,0.005321468,0.0002070685,0.001378713],"category_scores_gemma":[0.00006710598,0.0006134644,0.001426833,0.004184726,0.0004756619,0.0002214574,0.002763689,0.003052962,0.00001480732],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008821855,"about_ca_system_score_gemma":0.0003920742,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008032524,"about_ca_topic_score_gemma":0.00005076486,"domain_scores_codex":[0.9847421,0.009119282,0.001873735,0.001553781,0.001640654,0.001070462],"domain_scores_gemma":[0.9943494,0.001830615,0.001107527,0.002102946,0.0001410252,0.0004685558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.003646499,0.005763427,0.3611483,0.0003940611,0.4753848,0.0002398294,0.04348411,0.02171211,0.02831817,0.0009009981,0.03701114,0.02199655],"study_design_scores_gemma":[0.004492739,0.0003571404,0.07409041,0.000005395995,0.6075872,0.00004196377,0.002930753,0.005160277,0.01562962,0.0000674058,0.2884766,0.001160588],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9136582,0.06426994,0.000009108057,0.007517226,0.004474016,0.002007104,0.005991081,0.00003534577,0.002037968],"genre_scores_gemma":[0.9847175,0.001801022,0.0000569849,0.01105486,0.0007865235,0.0003657316,0.0001494308,0.00006736574,0.001000521],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2870579,"threshold_uncertainty_score":0.9996316,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}